Assignee
RGENTA THERAPEUTICS INC
US·0 granted patents·4 pending applications·0 citations·filing 2022–2022
Top patents by PatentIndex Score
4 records- 0154US2025026753A1Fused triazinone derivatives and methods of using the sameRGENTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0254US2025042879A1Heterocyclic substituted 1,3,4-thiadiazole and pyridazine compounds and methods of using the sameRGENTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0354US2025066389A1Heterocyclic amides and methods of using the sameRGENTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0454US2025122192A15-pyrimidinecarboxamide derivatives and methods of using the sameRGENTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →